Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | CASP6 | P55212 | 1/20 | 0.55 |
| ▸ | BACE1 | P56817 | 3/20 | 0.46 |
| ▸ | NCK1 | P16333 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12923092 | 0.86 | BACE1 (0.62) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL982393 | 0.86 | BACE1 (0.62) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL16974223 | 0.85 | CYP1A2 (0.55) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL31307097 | 0.85 | CYP1A2 (0.55) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL29444268 | 0.83 | CYP1A2 (1.00) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL161703 | 0.83 | CYP1A2 (1.00) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL16574004 | 0.82 | CYP1A2 (0.47) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL12436949 | 0.82 | CYP1A2 (0.52) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| Iodide SCHEMBL31142554 | 0.81 | CYP1A2 (0.95) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL28150727 | 0.81 | BACE1 (0.54) | CYP1A2KDM4ELMNABACE1NCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9127021-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2015-09-08 | — | — | US | disclosed |
| US-8933110-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-8785487-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2014-07-22 | — | — | US | disclosed |
| WO-2013087743-A1 | INHIBITORS OF HCV NS5A | F. HOFFMANN-LA ROCHE AG (CH) | 2013-06-20 | — | — | WO | disclosed |